Physician profile
Laura E Davis
NPI 1366693905
$4,266.46
in general payments reported to CMS, 2019-2025
40 companies · $1,557 in 2025
The $1,557 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.31 · 2022: $441 · 2023: $858 · 2024: $1,369 · 2025: $1,557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,783.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $830.42 | 2022-2025 | |
| Lilly USA, LLC | $533.01 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $369.16 | 2022-2025 | Caplyta |
| Novo Nordisk INC | $306.86 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Vanda Pharmaceuticals INC. | $291.06 | 2024-2025 | Fanapt, Hetlioz |
| Pfizer INC. | $262.39 | 2021-2025 | |
| Glaxosmithkline, LLC. | $197.59 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $179.61 | 2022-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $123.35 | 2022-2025 | Otezla, Repatha, Otezla |
| Otsuka America Pharmaceutical, INC. | $96.28 | 2024-2025 | Rexulti |
| Dynavax Technologies Corporation | $86.20 | 2024-2025 | Heplisav-B |
| Verona Pharma, INC. | $72.87 | 2025 | Ohtuvayre |
| Takeda Pharmaceuticals U.S.A., INC. | $70.45 | 2022-2025 | Trintellix |
| Novartis Pharmaceuticals Corporation | $70.04 | 2022-2024 | |
| Axsome Therapeutics, INC. | $68.15 | 2023-2024 | Auvelity |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $54.09 | 2022-2025 | Spravato |
| Phathom Pharmaceuticals, INC. | $52.92 | 2023-2025 | Voquezna |
| Astellas Pharma US INC | $51.63 | 2023-2025 | Myrbetriq, Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $51.60 | 2024-2025 | |
| Alkermes, INC. | $49.27 | 2025 | Lybalvi |
| Exact Sciences Corporation | $40.90 | 2024-2025 | Cologuard Collection Kit |
| Insulet Corporation | $39.78 | 2025 | Omnipod |
| Kowa Pharmaceuticals America, INC. | $31.96 | 2025 | Zoryve |
| Beta Bionics, INC. | $31.10 | 2024 | Ilet Bionic Pancreas |
| Tonix Medicines, INC. | $28.09 | 2025 | Tonmya |
| Lundbeck LLC | $25.78 | 2025 | Rexulti |
| Almatica Pharma LLC | $25.09 | 2023 | Gralise, Loreev Xr |
| Teva Pharmaceuticals USA, INC. | $23.05 | 2025 | Austedo Xr |
| Abiomed | $21.10 | 2024 | Impella |
| Blueprint Medicines Corporation | $20.53 | 2024 | Ayvakit |
| Ultragenyx Pharmaceutical INC. | $19.88 | 2024 | Crysvita |
| Medtronic, INC. | $18.91 | 2025 | Minimed 780g |
| Merck Sharp & Dohme LLC | $16.78 | 2022 | |
| Idorsia Pharmaceuticals US INC | $16.60 | 2023 | Quviviq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.46 | 2025 | Jardiance |
| Abbott Laboratories | $15.43 | 2024 | Freestyle Libre 3 |
| Hologic Sales and Service, LLC | $15.01 | 2022 | |
| Dexcom, INC. | $14.95 | 2024 | Dexcom G6 Transmitter |
| Inspire Medical Systems, INC. | $14.65 | 2023 | Inspire |
| Axonics, INC. | $14.46 | 2024 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.